セッション情報

ポスター

第58回・2020年・京都
ポスター
ポスター
Pancreas/Others
開催回
第58回・2020年・京都

Olaparib as maintenance treatment following first- line platinum-based chemotherapy (PBC) in patients (pts) with a germline BRCA mutation and metastatic pancreatic cancer (mPC): Phase III POLO trial

演題番号 : P-526

Joon Oh Park:1、Hedy L. Kindler:2、Pascal Hammel:3、Michele Reni:4、Eric Van Cutsem:5、Teresa Macarulla Mercade:6、Michael J. Hall:7、Daniel Hochhauser:8、Dirk Arnold:9、Do-Youn Oh:10、Anke C. Reinacher-Schick:11、Algül Hana:12、O'reilly Eileen M.:13、Gershon Y. Locker:14、Talia Golan:15

1:Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea、2:The University of Chicago, Chicago, IL, USA、3:Hôpital Beaujon (AP-HP), Clichy, and University Paris VII, Paris, France、4:IRCCS Ospedale, San Raffaele Scientific Institute, Milan, Italy、5:University Hospitals Gasthuisberg, Leuven and KU Leuven, Leuven, Belgium、6:Vall d'Hebron University Hospital and Vall d'Hebron Institute of Oncology, Barcelona, Spain、7:Fox Chase Cancer Center, Philadelphia, PA, USA、8:University College London Cancer Institute, London, UK、9:Asklepios Tumorzentrum Hamburg AK Altona, Hamburg, Germany、10:Seoul National University Hospital, Seoul, South Korea、11:St. Josef-Hospital, Ruhr University Bochum, Bochum, Germany、12:Klinikum rechts der Isar, Department of Internal Medicine II, Technische Universität München, Munich, Germany、13:Memorial Sloan Kettering Cancer Center, New York, NY, USA、14:AstraZeneca, Gaithersburg, MD, USA、15:The Oncology Institute, Sheba Medical Center at Tel-Hashomer, Tel Aviv University, Tel Aviv, Israel

Olaparib as maintenance treatment following first- line platinum-based chemotherapy (PBC) in patients (pts) with a germline BRCA mutation and metastatic pancreatic cancer (mPC): Phase III POLO trial

Clinical significance of site-specific metastases in pancreatic cancer: a study based on both clinical trial and real-world data

演題番号 : P-527

Hang Junjie:1、Zhu Lina:1、Zhou Siyuan:1、Zhou Yang:1、Zhang Tiening:3、Wu Lixia:2、Zee Benny:4

1:Department of Oncology,Changzhou No.2 People's Hospital、2:Department of Oncology,Shanghai JingAn District ZhaBei Central Hospital、3:Department of Radiotherapy,Shanghai General Hospital、4:JC School of Public Health and Primary Care,The Chinese University of Hong Kong

Clinical significance of site-specific metastases in pancreatic cancer: a study based on both clinical trial and real-world data

Development and validation of a radiomics nomogram for prediction of liver metastases in pancreatic cancer with machine learning methods

演題番号 : P-528

Hang Junjie:1、Yin Ruohan:1、Shao Yueting:1、Xu Kequn:1、Wu Lixia:2

1:Department of Oncology,Changzhou No.2 People's Hospital、2:Department of Oncology,Shanghai JingAn District ZhaBei Central Hospital

Development and validation of a radiomics nomogram for prediction of liver metastases in pancreatic cancer with machine learning methods